Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis
Author Information
Author(s): Neyns B. MD PhD, Meert V. MD, Vandenbroucke F. MD
Primary Institution: Universitair Ziekenhuis Brussel, Brussels, Belgium
Hypothesis
Can cetuximab be safely used in patients with metastatic colorectal cancer who also have psoriasis?
Conclusion
Cetuximab treatment can be safely offered to colorectal cancer patients suffering from psoriasis, leading to remission of cancer and improvement of psoriasis.
Supporting Evidence
- Cetuximab is effective for treating metastatic colorectal cancer.
- The patient had a life-long history of extensive psoriasis.
- Psoriasis lesions improved significantly during cetuximab treatment.
- The patient experienced almost complete regression of liver metastases.
Takeaway
A man with cancer and psoriasis got better after taking a medicine called cetuximab, which usually causes skin problems, but helped his skin instead.
Methodology
Case report detailing the treatment of a single patient with cetuximab.
Potential Biases
Potential bias due to the single-case nature of the report.
Limitations
Only one patient was studied, limiting the generalizability of the findings.
Participant Demographics
An 80-year-old male with a history of extensive psoriasis.
Want to read the original?
Access the complete publication on the publisher's website